312 related articles for article (PubMed ID: 16677734)
1. Identification of penetration enhancers for testosterone transdermal delivery from spray formulations.
Leichtnam ML; Rolland H; Wüthrich P; Guy RH
J Control Release; 2006 Jun; 113(1):57-62. PubMed ID: 16677734
[TBL] [Abstract][Full Text] [Related]
2. Formulation and evaluation of a testosterone transdermal spray.
Leichtnam ML; Rolland H; Wüthrich P; Guy RH
J Pharm Sci; 2006 Aug; 95(8):1693-702. PubMed ID: 16795012
[TBL] [Abstract][Full Text] [Related]
3. Discovery of transdermal penetration enhancers by high-throughput screening.
Karande P; Jain A; Mitragotri S
Nat Biotechnol; 2004 Feb; 22(2):192-7. PubMed ID: 14704682
[TBL] [Abstract][Full Text] [Related]
4. Identification and assessment of permeability enhancing vehicles for transdermal delivery of glucosamine hydrochloride.
Han IH; Choi SU; Nam DY; Park YM; Kang MJ; Kang KH; Kim YM; Bae G; Oh IY; Park JH; Ye JS; Choi YB; Kim DK; Lee J; Choi YW
Arch Pharm Res; 2010 Feb; 33(2):293-9. PubMed ID: 20195831
[TBL] [Abstract][Full Text] [Related]
5. Enhancement of transdermal testosterone delivery by supersaturation.
Leichtnam ML; Rolland H; Wüthrich P; Guy RH
J Pharm Sci; 2006 Nov; 95(11):2373-9. PubMed ID: 16886189
[TBL] [Abstract][Full Text] [Related]
6. Effect of chemical enhancers on percutaneous absorption of daphnetin in isopropyl myristate vehicle across rat skin in vitro.
Wen Z; Fang L; He Z
Drug Deliv; 2009 May; 16(4):214-23. PubMed ID: 19280376
[TBL] [Abstract][Full Text] [Related]
7. Transdermal delivery system for zidovudine: in vitro, ex vivo and in vivo evaluation.
Narishetty ST; Panchagnula R
Biopharm Drug Dispos; 2004 Jan; 25(1):9-20. PubMed ID: 14716748
[TBL] [Abstract][Full Text] [Related]
8. The effects of vehicle and region of application on in vitro penetration of testosterone through canine skin.
Mills PC; Magnusson BM; Cross SE
Vet J; 2006 Mar; 171(2):276-80. PubMed ID: 16490709
[TBL] [Abstract][Full Text] [Related]
9. Microemulsions as transdermal drug delivery vehicles.
Kogan A; Garti N
Adv Colloid Interface Sci; 2006 Nov; 123-126():369-85. PubMed ID: 16843424
[TBL] [Abstract][Full Text] [Related]
10. Combined effects of iontophoretic and chemical enhancement on drug delivery. II. Transport across human and murine skin.
Nolan LM; Corish J; Corrigan OI; Fitzpatrick D
Int J Pharm; 2007 Aug; 341(1-2):114-24. PubMed ID: 17502130
[TBL] [Abstract][Full Text] [Related]
11. Transdermal delivery of nicardipine: an approach to in vitro permeation enhancement.
Aboofazeli R; Zia H; Needham TE
Drug Deliv; 2002; 9(4):239-47. PubMed ID: 12511202
[TBL] [Abstract][Full Text] [Related]
12. Effect of vehicles and enhancers on the topical delivery of cyclosporin A.
Liu H; Li S; Wang Y; Yao H; Zhang Y
Int J Pharm; 2006 Mar; 311(1-2):182-6. PubMed ID: 16439077
[TBL] [Abstract][Full Text] [Related]
13. Effect of penetration enhancers on the release and skin permeation of bupranolol from reservoir-type transdermal delivery systems.
Babu RJ; Pandit JK
Int J Pharm; 2005 Jan; 288(2):325-34. PubMed ID: 15620873
[TBL] [Abstract][Full Text] [Related]
14. Feasibility studies of dermal delivery of paclitaxel with binary combinations of ethanol and isopropyl myristate: role of solubility, partitioning and lipid bilayer perturbation.
Panchagnula R; Desu H; Jain A; Khandavilli S
Farmaco; 2005; 60(11-12):894-9. PubMed ID: 16126203
[TBL] [Abstract][Full Text] [Related]
15. Effect of fatty acids on the transdermal delivery of donepezil: in vitro and in vivo evaluation.
Choi J; Choi MK; Chong S; Chung SJ; Shim CK; Kim DD
Int J Pharm; 2012 Jan; 422(1-2):83-90. PubMed ID: 22037444
[TBL] [Abstract][Full Text] [Related]
16. Transdermal delivery of zidovudine (AZT): the effects of vehicles, enhancers, and polymer membranes on permeation across cadaver pig skin.
Suwanpidokkul N; Thongnopnua P; Umprayn K
AAPS PharmSciTech; 2004 Aug; 5(3):e48. PubMed ID: 15760081
[TBL] [Abstract][Full Text] [Related]
17. Limonene GP1/PG organogel as a vehicle in transdermal delivery of haloperidol.
Lim PF; Liu XY; Kang L; Ho PC; Chan YW; Chan SY
Int J Pharm; 2006 Mar; 311(1-2):157-64. PubMed ID: 16451823
[TBL] [Abstract][Full Text] [Related]
18. Influence of penetration enhancer on drug permeation from volatile formulations.
Santos P; Watkinson AC; Hadgraft J; Lane ME
Int J Pharm; 2012 Dec; 439(1-2):260-8. PubMed ID: 23000063
[TBL] [Abstract][Full Text] [Related]
19. Formulation and in vitro/in vivo evaluation of levodopa transdermal delivery systems.
Lee KE; Choi YJ; Oh BR; Chun IK; Gwak HS
Int J Pharm; 2013 Nov; 456(2):432-6. PubMed ID: 24008082
[TBL] [Abstract][Full Text] [Related]
20. Enhanced transdermal delivery of loratadine from the EVA matrix.
Cho CW; Choi JS; Kim SJ; Shin SC
Drug Deliv; 2009 May; 16(4):230-5. PubMed ID: 19514983
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
